GLP-1 drugs like Ozempic linked to lower colorectal cancer death risk

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss. Recent studies have found that GLP-1 medications may be linked to a decreased risk for certain cancers, including colorectal cancer. A new study found GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer.

Leave a Reply

Your email address will not be published.

*

X

[contact-form-7 id="9" title="Tell a Friend"]